Angitia Biopharmaceuticals
About:
Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.
Website: https://angitiabio.com/
Top Investors: OrbiMed, Hillhouse Ventures, Oriza Holdings, Legend Capital, Morningside Venture Investments
Description:
Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics for serious musculoskeletal diseases.
Total Funding Amount:
$156M
Headquarters Location:
Guangzhou, Guangdong, China
Founded Date:
2018-01-01
Contact Email:
info(AT)angitiabio.com
Founders:
Number of Employees:
101-250
Last Funding Date:
2024-02-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai